BenzingaAugust 10, 2026 at 3:22 AM NY25 days ago

Apogee Therapeutics Q2 EPS $(1.14) Misses $(1.05) Estimate

Apogee Therapeutics (NASDAQ:APGE) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $(1.05) by 8.57 percent. This is a 0.88 percent decrease over losses of $(1.13) per share

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga

Read at Source

Companies in This Story

APGEApogee Therapeutics Inc135.11+ 0.02%

Companies in This Story

Related Stories